ES2182900T3 - Extractos de cartilago de tiburon, que tienen una actividad anti-angiogenica y efecto en regresion de tumor, proceso para su produccion. - Google Patents

Extractos de cartilago de tiburon, que tienen una actividad anti-angiogenica y efecto en regresion de tumor, proceso para su produccion.

Info

Publication number
ES2182900T3
ES2182900T3 ES95916523T ES95916523T ES2182900T3 ES 2182900 T3 ES2182900 T3 ES 2182900T3 ES 95916523 T ES95916523 T ES 95916523T ES 95916523 T ES95916523 T ES 95916523T ES 2182900 T3 ES2182900 T3 ES 2182900T3
Authority
ES
Spain
Prior art keywords
supernatant
vivo
tumor
extracts
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95916523T
Other languages
English (en)
Inventor
Eric Dupont
Paul Brazeau
Christina Juneau
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Les Laboratories Aeterna Inc
Original Assignee
Les Laboratories Aeterna Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Les Laboratories Aeterna Inc filed Critical Les Laboratories Aeterna Inc
Application granted granted Critical
Publication of ES2182900T3 publication Critical patent/ES2182900T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/60—Fish, e.g. seahorses; Fish eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Abstract

LA PRESENTE INVENCION SE REFIERE A EXTRACTOS DE CARTILAGO DE TIBURON Y A UN METODO PARA PRODUCIRLOS, ESTOS EXTRACTOS TIENEN PROPIEDADES ANTIANGIOGENICAS (SE HA OBSERVADO IN VIVO LA REDUCCION DEL AREA DE VASOS SANGUINEOS EN TUMORES INDUCIDOS EXPERIMENTALMENTE), ACTIVIDAD REGRESIVA DEL TUMOR IN VIVO ASI COMO DEMUESTRAN UN EFECTO INHIBITORIO DIRECTO EN LAS LINEAS CELULARES DEL TUMOR. ESTE PROCESO NO NECESITA DE NINGUN PRODUCTO O SOLVENTE DESNATURALIZADOR NI EL USO DE NINGUNA ENZIMA. CONSISTE EN OBTENER UNA MEZCLA DEL CONJUNTO DEL CARTILAGO EN UNA SOLUCION ACUOSA DE PH NEUTRAL, PREFERIBLEMENTE AGUA PURA, ESTA MEZCLA ES CENTRIFUGADA GUARDANDOSE LA BOLITA Y EL SOBRENADANTE PARA UN PROCESAMIENTO POSTERIOR. LA BOLITA SE LIOFILIZA Y PRUEBA EN LAS ACTIVIDADES ANTITUMORALES Y ANTIANGIOGENICA IN VIVO E IN VITRO, CON O SIN SOBRENADANTE. EL SOBRENADANTE HA DEMOSTRADO TENER IN VIVO ACTIVIDAD ANGIOGENICA Y DE REGRESION TUMORAL. LA COMPOSICION DEL SOBRENADANTE SE HA INVESTIGADO DE DIFERENTES FORMAS. EL FRACCIONAMIENTO DE ESTE SOBRENADANTE PERMITIO LA CARACTERIZACION DE ALGUNOS DE SUS COMPONENTES ACTIVOS. LA ACTIVIDAD DIRECTA IN VIVO DE LAS FRACCIONES HA SIDO PROBADA EN LAS LINEAS CELULARES TUMORALES. ADEMAS SE ASUME QUE EL SOBRENADANTE NO FRACCIONADO TIENE LA MISMA ACTIVIDAD IN VITRO. LA LIOFILIZACION DESTRUYE SUSTANCIALMENTE LA ACTIVIDAD DE ESTAS FRACCIONES LIQUIDAS SIN QUE SE HAYA OBSERVADO ESTA DESTRUCCION EN EL EXTRACTO SOLIDO.
ES95916523T 1994-04-28 1995-04-21 Extractos de cartilago de tiburon, que tienen una actividad anti-angiogenica y efecto en regresion de tumor, proceso para su produccion. Expired - Lifetime ES2182900T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US23401994A 1994-04-28 1994-04-28
US08/384,555 US5618925A (en) 1994-04-28 1995-02-03 Extracts of shark cartilage having an anti-angiogenic activity and an effect on tumor regression; process of making thereof

Publications (1)

Publication Number Publication Date
ES2182900T3 true ES2182900T3 (es) 2003-03-16

Family

ID=26927471

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95916523T Expired - Lifetime ES2182900T3 (es) 1994-04-28 1995-04-21 Extractos de cartilago de tiburon, que tienen una actividad anti-angiogenica y efecto en regresion de tumor, proceso para su produccion.

Country Status (24)

Country Link
US (2) US5618925A (es)
EP (1) EP0759765B1 (es)
JP (1) JPH09512563A (es)
KR (1) KR100378787B1 (es)
CN (2) CN1147305C (es)
AT (1) ATE224198T1 (es)
BG (1) BG62954B1 (es)
BR (1) BR9507552A (es)
CA (1) CA2188793C (es)
CZ (1) CZ290520B6 (es)
DE (1) DE69528258T2 (es)
DK (1) DK0759765T3 (es)
ES (1) ES2182900T3 (es)
FI (1) FI117375B (es)
HU (1) HU220784B1 (es)
IS (1) IS1975B (es)
NO (1) NO317674B1 (es)
NZ (1) NZ284407A (es)
PL (1) PL181981B1 (es)
PT (1) PT759765E (es)
RO (1) RO114868B1 (es)
RU (1) RU2156132C2 (es)
SI (1) SI0759765T1 (es)
WO (1) WO1995032722A1 (es)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5618925A (en) * 1994-04-28 1997-04-08 Les Laboratories Aeterna Inc. Extracts of shark cartilage having an anti-angiogenic activity and an effect on tumor regression; process of making thereof
US6028118A (en) * 1996-08-08 2000-02-22 Les Laboratoires Aeterna Inc. Methods of using extracts of shark cartilage
US6380366B1 (en) * 1994-04-28 2002-04-30 Les Laboratoires Aeterna Inc. Shark cartilage extract:process of making, methods of using and compositions thereof
US6025334A (en) * 1994-04-28 2000-02-15 Les Laboratoires Aeterna Inc. Extracts of shark cartilage having anti-collagenolytic, anti-inflammatory, anti-angiogenic and anti-tumoral activities; process of making, methods of using and compositions thereof
WO1996023512A1 (en) * 1995-02-03 1996-08-08 Les Laboratoires Aeterna Inc. Extracts of shark cartilage, process of production and uses thereof
US5843920A (en) * 1996-09-16 1998-12-01 Biocell Technology, Llc Anionic saccharides for extraction of anti-angiogenic protein from cartilage
AU6639898A (en) * 1997-02-20 1998-09-09 Industrial Research Limited Angiogenesis inhibitors and activators from shark cartilage
DE69815310T2 (de) 1997-03-11 2004-04-22 Les Laboratoires Aeterna Inc. Zubereitungen zur tumorbehandlung enthaltend hai-knorpelextrakte und antineoplastische mittel
KR100732322B1 (ko) * 1997-07-11 2007-06-25 에프엑스 라이프 싸이언스즈 인터내셔널 게엠베하 피에이취에프 과다 또는 세포내 칼슘 과다와 관련한질병을 치료하기 위한 상어 연골에서 유래한 조제물
US5840342A (en) * 1997-09-17 1998-11-24 Raithaus; Lawrence R. Shark liver extract for stimulating the immune system
FR2778558B1 (fr) * 1998-05-12 2001-02-16 Oreal Utilisation d'inhibiteur de metalloproteinases pour induire et/ou stimuler la croissance des cheveux ou des poils et/ou freiner leur chute
CA2333147C (en) 1998-07-13 2012-02-07 Board Of Regents, The University Of Texas System Cancer treatment methods using antibodies to aminophospholipids
US20020009501A1 (en) * 1998-07-23 2002-01-24 Eric Dupont Preparation of cartilage extracts using organic solvents
US6168807B1 (en) 1998-07-23 2001-01-02 Les Laboratoires Aeterna Inc. Low molecular weight components of shark cartilage, processes for their preparation and therapeutic uses thereof
EP1234585A3 (en) 1998-09-04 2004-01-21 The Regents Of The University Of Michigan Methods and compositions for the prevention or treatment of cancer
CN1064690C (zh) * 1998-09-10 2001-04-18 中国人民解放军海军医学研究所 鲨鱼软骨血管生成抑制因子及其分离纯化方法
US7361643B2 (en) 2000-02-09 2008-04-22 University Of Puerto Rico Methods for inhibiting angiogenesis
JP2004516272A (ja) * 2000-12-20 2004-06-03 インダストリアル リサーチ リミテッド サメ肉抽出物
AUPR222300A0 (en) * 2000-12-21 2001-01-25 Life Therapeutics Limited Electrophoresis device and method
EP1401462A1 (en) * 2001-05-30 2004-03-31 Wackvom Limited Compositions containing an active fraction isolated from ganoderma lucidum and methods of use
US20030087830A1 (en) * 2001-06-12 2003-05-08 Eric Dupont Low molecular weight components of cartilage, complexes of metals with amino acids, DI-peptides and analogs thereof; processes for preparation and therapeutic uses thereof
US7309501B2 (en) * 2001-06-21 2007-12-18 Mote Marine Laboratory Conditioned media to inhibit growth of tumor cells
US6908627B2 (en) * 2001-06-21 2005-06-21 Mote Marine Laboratory Conditioned media for inhibiting growth of tumor cells
WO2003068249A1 (en) 2002-02-15 2003-08-21 Ocean Nutrition Canada Limited Shark cartilage extracts and use thereof for immunomodulation
ES2358730T3 (es) 2002-07-15 2011-05-13 Board Of Regents, The University Of Texas System Anticuerpos seleccionados y péptidos de duramicina que se enlazan a fosfolípidos aniónicos y aminofosfolípidos y sus usos en el tratamiento de infecciones virales y del cáncer.
WO2004083257A1 (ja) * 2003-03-20 2004-09-30 Hosokawa Micron Corporation 軟骨魚類から単離されたプロテオグリカンおよびその製造方法
US7067123B2 (en) 2003-04-29 2006-06-27 Musculoskeletal Transplant Foundation Glue for cartilage repair
US7901457B2 (en) * 2003-05-16 2011-03-08 Musculoskeletal Transplant Foundation Cartilage allograft plug
ES2223291B1 (es) * 2003-08-06 2006-03-16 Bioiberica, S.A. Nuevo uso terapeutico de condroitin sulfato.
EP2338442B1 (en) 2003-12-11 2013-01-30 Isto Technologies Inc. Particulate cartilage system
CA3031283A1 (en) 2004-01-22 2005-08-04 University Of Miami Topical co-enzyme q10 formulations and methods of use
CN100377741C (zh) * 2004-02-23 2008-04-02 江卫世 注射用复方骨肽及其制备工艺
US20050288796A1 (en) * 2004-06-23 2005-12-29 Hani Awad Native soft tissue matrix for therapeutic applications
US7837740B2 (en) * 2007-01-24 2010-11-23 Musculoskeletal Transplant Foundation Two piece cancellous construct for cartilage repair
WO2006059236A2 (en) * 2004-11-16 2006-06-08 Aeterna Zentaris Inc. Method of using cartilage extract for increasing blood parameters
US7815926B2 (en) * 2005-07-11 2010-10-19 Musculoskeletal Transplant Foundation Implant for articular cartilage repair
WO2007025290A2 (en) 2005-08-26 2007-03-01 Isto Technologies, Inc. Implants and methods for repair, replacement and treatment of joint disease
JP2009508596A (ja) 2005-09-19 2009-03-05 ヒストジェニックス コーポレイション 細胞支持基材及びその調製方法
DE102006060247A1 (de) * 2006-09-15 2008-03-27 Ossacur Ag Differenzierung von Stammzellen
US8163549B2 (en) 2006-12-20 2012-04-24 Zimmer Orthobiologics, Inc. Method of obtaining viable small tissue particles and use for tissue repair
US8435551B2 (en) 2007-03-06 2013-05-07 Musculoskeletal Transplant Foundation Cancellous construct with support ring for repair of osteochondral defects
WO2008128075A1 (en) 2007-04-12 2008-10-23 Isto Technologies, Inc. Compositions and methods for tissue repair
WO2009060198A1 (en) 2007-11-09 2009-05-14 Peregrine Pharmaceuticals, Inc. Anti-vegf antibody compositions and methods
WO2009111069A1 (en) 2008-03-05 2009-09-11 Musculoskeletal Transplant Foundation Cancellous constructs, cartilage particles and combinations of cancellous constructs and cartilage particles
CA2749750C (en) * 2008-04-15 2014-01-28 Immanence Integrale Dermo Correction Inc. Skin care compositions and methods of use thereof
AU2009274512A1 (en) 2008-07-25 2010-01-28 The Regents Of The University Of Colorado Clip inhibitors and methods of modulating immune function
US20100274362A1 (en) * 2009-01-15 2010-10-28 Avner Yayon Cartilage particle tissue mixtures optionally combined with a cancellous construct
CN101899104B (zh) * 2010-05-28 2012-04-18 暨南大学 一种鲨鱼软骨血管生成抑制因子小分子多肽及其生产纯化方法和应用
CN101891811B (zh) * 2010-05-28 2011-11-09 暨南大学 一种鲨鱼血管生成抑制因子及其生产纯化方法和应用
CN103429608B (zh) * 2011-01-19 2016-08-03 国立大学法人弘前大学 蛋白多糖的大量制备方法
US20140178343A1 (en) 2012-12-21 2014-06-26 Jian Q. Yao Supports and methods for promoting integration of cartilage tissue explants
US10077420B2 (en) 2014-12-02 2018-09-18 Histogenics Corporation Cell and tissue culture container
CN104894200B (zh) * 2015-05-12 2020-10-30 浙江海洋学院 路氏双髻鲨软骨血管生成抑制因子的制备方法
KR101628982B1 (ko) 2015-11-27 2016-06-09 김준혁 항종양 및 면역 증강용 건강식품 조성물
EP3576726A1 (en) 2017-02-06 2019-12-11 Massachusetts Institute Of Technology Methods and products related to glutaminase inhibitors
CN109394786A (zh) * 2018-10-26 2019-03-01 西交利物浦大学 一种抗肿瘤的药物组合物
WO2020203812A1 (ja) * 2019-03-29 2020-10-08 学校法人慶應義塾 魚介類由来成分による低酸素応答制御
WO2020251412A2 (ru) * 2019-06-14 2020-12-17 Общество С Ограниченной Ответственностью "Айтупайф" (Ооо "Айтулайф") Способ получения йодированных белков с детерминированным содержанием йода
CN112986499A (zh) * 2021-02-26 2021-06-18 山西奥瑞生物材料有限公司 一种同种骨植入材料残余水量均匀度测定方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3478146A (en) * 1965-02-26 1969-11-11 Leslie L Balassa Wound-healing cartilage powder extracting process
US4042457A (en) * 1975-11-10 1977-08-16 Rush-Presbyterian-St. Luke's Medical Center Preparation of tissue invasion inhibitor and method of treatment utilizing the inhibitor
US4822607A (en) * 1976-10-29 1989-04-18 Lescarden Ltd. Anti-tumor agent and method
US4243582A (en) * 1979-04-26 1981-01-06 Monsanto Company Novel glycoproteins from bovine cartilage
US4350682A (en) * 1979-05-11 1982-09-21 Lescarden Ltd. Cartilage extraction processes and products
US4356261A (en) * 1980-04-22 1982-10-26 Rush-Presbyterian-St. Luke's Medical Center Anti-invasion factor containing cultures
US4473551A (en) * 1982-08-23 1984-09-25 Faxon Pharmaceuticals, Inc. Anti-inflammatory composition
US4656137A (en) * 1985-09-12 1987-04-07 Lescarden Inc Method of processing animal cartilage
US4749522A (en) * 1985-10-31 1988-06-07 Angio-Medical Corporation Supercritical fluid extraction of animal derived materials
US4746729A (en) * 1986-07-30 1988-05-24 Kuettner Klaus E Cartilage-derived leukocyte elastase-inhibitor
US5075112A (en) * 1990-02-12 1991-12-24 Cartilage Technologies Inc. Method of and dosage unit for inhibiting angiogenesis or vascularization in an animal using shark cartilage
AU5596494A (en) * 1992-11-30 1994-06-22 I. William Lane Processing shark cartilage
ES2290074T3 (es) * 1993-07-19 2008-02-16 Angiotech Pharmaceuticals, Inc. Composiciones anti-angiogenicas que contienen taxol y un vehiculo no biodegradable y su uso.
US5618925A (en) * 1994-04-28 1997-04-08 Les Laboratories Aeterna Inc. Extracts of shark cartilage having an anti-angiogenic activity and an effect on tumor regression; process of making thereof

Also Published As

Publication number Publication date
NZ284407A (en) 1998-04-27
HU9602975D0 (en) 1997-01-28
WO1995032722A1 (en) 1995-12-07
RU2156132C2 (ru) 2000-09-20
EP0759765A1 (en) 1997-03-05
NO964547L (no) 1996-12-30
KR100378787B1 (ko) 2003-06-19
BR9507552A (pt) 1997-08-05
SI0759765T1 (en) 2003-02-28
US5618925A (en) 1997-04-08
PL317076A1 (en) 1997-03-03
NO964547D0 (no) 1996-10-25
ATE224198T1 (de) 2002-10-15
HU220784B1 (hu) 2002-05-28
FI964327A (fi) 1996-12-20
CN1147305C (zh) 2004-04-28
DK0759765T3 (da) 2003-01-27
CA2188793C (en) 2001-01-16
BG100941A (en) 1997-07-31
US5985839A (en) 1999-11-16
IS4379A (is) 1996-10-25
FI117375B (fi) 2006-09-29
CN1153477A (zh) 1997-07-02
DE69528258T2 (de) 2003-04-17
PT759765E (pt) 2003-02-28
CN1541656A (zh) 2004-11-03
EP0759765B1 (en) 2002-09-18
IS1975B (is) 2005-01-14
PL181981B1 (en) 2001-10-31
FI964327A0 (fi) 1996-10-28
RO114868B1 (ro) 1999-08-30
AU2300195A (en) 1995-12-21
CZ314196A3 (en) 1997-04-16
DE69528258D1 (de) 2002-10-24
NO317674B1 (no) 2004-11-29
CZ290520B6 (cs) 2002-08-14
KR970702729A (ko) 1997-06-10
CA2188793A1 (en) 1995-12-07
AU719118B2 (en) 2000-05-04
HUT76554A (en) 1997-09-29
JPH09512563A (ja) 1997-12-16
BG62954B1 (bg) 2000-12-29

Similar Documents

Publication Publication Date Title
ES2182900T3 (es) Extractos de cartilago de tiburon, que tienen una actividad anti-angiogenica y efecto en regresion de tumor, proceso para su produccion.
Liang et al. Nutritional compositions of Indian Moringa oleifera seed and antioxidant activity of its polypeptides
Pataro et al. Improving the extraction of juice and anthocyanins from blueberry fruits and their by-products by application of pulsed electric fields
Peintner et al. The iceman's fungi
Fayad et al. Macroalga Padina pavonica water extracts obtained by pressurized liquid extraction and microwave-assisted extraction inhibit hyaluronidase activity as shown by capillary electrophoresis
Liu et al. Effects of endogenous cysteine proteinases on structures of collagen fibres from dermis of sea cucumber (Stichopus japonicus)
BR0016032A (pt) Colágeno
DE69625698D1 (de) Extrakte aus haifischknorpel
Liu et al. Action of trypsin on structural changes of collagen fibres from sea cucumber (Stichopus japonicus)
Yamada et al. A novel stiffening factor inducing the stiffest state of holothurian catch connective tissue
ES2188672T3 (es) Extractos de cartilagos de tiburon, procedimiento para la obtencion y utilizaciones de los mismos.
ES2178698T3 (es) Preparado de lino, su uso y su produccion.
Shen et al. Liquefaction of chicken sternal cartilage by steam explosion to isolate chondroitin sulfate
Li et al. In vitro antioxidant and anti-aging properties of swim bladder peptides from Atlantic cod (Gadus morhua)
Nagai et al. Collagen of octopus Callistoctopus arakawai arm
Xiao et al. Effect of solution p H and activated carbon dosage on the decolourization ability, nitrogen components and antioxidant activity of peanut meal hydrolysate
AR008189A1 (es) Proceso para tratar proteinas vegetales y productos alimenticios preparados a partir de las mismas
WO2004041076A3 (en) Methods of detecting colorectal cancer
Basha et al. Preliminary phytochemical screening and invitro angiotension activity of bioactive compound-steroid isolated from Sargassum ilicifolium
Zhang et al. Effect of infrared radiation on activity and conformation of polyphenol oxidase from Acetes chinensis
KR100229948B1 (ko) 미색류 껍질로부터 황산다당류의 추출 및 정제방법
Ganot et al. An alternative and effective method for extracting skeletal organic matrix adapted to the red coral Corallium rubrum
JP2007269767A (ja) 藻類の加温加圧抽出方法
Giorgobiani et al. Possible role of endogenous growth inhibitors in regeneration of organs: searching for new approaches
Bateman et al. The effects of selected Australian snake venoms on tumour-associated microvascular endothelial cells (TAMECs) in vitro